The genetic defect-adenosine deaminase (ADA)
deficiency may be cured permanently by
Introducing bone marrow cells producing
ADA into cells at early embryonic stages
Periodic infusion of genetically engineered
lymphocytes having functional ADA cDNA
Administering adenosine deaminase
activators
Enzyme replacement therapy
